Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Muscle Weakness

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Muscle Weakness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attaix, D; Cardenas, DM; Cervek, M; Combaret, L; Debiton, E; Le Bricon, T; Madelmont, JC; Pouch, MN; Samuels, SE; Taillandier, D; Temparis, S; Tilignac, T1

Other Studies

1 other study(ies) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Muscle Weakness

ArticleYear
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
    Cancer research, 2002, May-15, Volume: 62, Issue:10

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cachexia; Cisplatin; Colonic Neoplasms; Cysteine Endopeptidases; Female; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Multienzyme Complexes; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Nitrosourea Compounds; Proteasome Endopeptidase Complex; Rats; Rats, Inbred F344; RNA, Messenger; Ubiquitin

2002